Jury Told Juno's Bid For $752M Patent Damages 'Just Crazy'
Juno Therapeutics and Sloan Kettering's bid for $752 million in damages over Kite Pharma's alleged infringement of a cancer immunotherapy patent is "just crazy," Kite's attorney told a California federal jury...To view the full article, register now.
Already a subscriber? Click here to view full article